Dr. Patrick Griffin, M.D.
What this data tells you about Dr. Griffin
Dr. Patrick Griffin is a student in an organized health care education/training program in Fort Worth, TX, with 15 years in practice. Based on federal Medicare data, Dr. Griffin performed 39,673 Medicare services across 2,783 unique beneficiaries.
Between the years covered by Open Payments, Dr. Griffin received a total of $2,399 from 40 pharmaceutical and/or device companies across 132 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Griffin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 12,800 | $0 | $2 |
| Contrast dye for imaging (iodine-based) | 8,235 | $0 | $3 |
| Darbepoetin injection (Aranesp) for anemia | 7,195 | $2 | $20 |
| Denosumab injection (Prolia/Xgeva) | 1,980 | $18 | $66 |
| Blood draw (venipuncture) | 1,148 | $8 | $20 |
| Complete blood count (CBC) with differential | 1,092 | $8 | $36 |
| Comprehensive metabolic blood panel | 1,041 | $10 | $64 |
| Dexamethasone injection (steroid) | 1,035 | $0 | $1 |
| Office visit, established patient (30-39 min) | 658 | $96 | $368 |
| Injection, granisetron hydrochloride, 100 mcg | 440 | $0 | $24 |
| Office visit, established patient (20-29 min) | 311 | $62 | $250 |
| Immunoglobulin level test | 273 | $9 | $56 |
| Hospital follow-up visit, moderate complexity | 261 | $62 | $247 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 233 | $22 | $157 |
| Measurement of immunoglobulin light chains | 200 | $17 | $60 |
| Administration of chemotherapy into vein, 1 hour or less | 185 | $100 | $707 |
| Lactate dehydrogenase (enzyme) level | 151 | $6 | $31 |
| Injection, zoledronic acid, 1 mg | 149 | $6 | $431 |
| Carcinoembryonic antigen (cea) protein level | 146 | $19 | $99 |
| Ferritin level test (iron stores) | 127 | $13 | $60 |
| Iron level test | 127 | $6 | $27 |
| Iron binding capacity test | 127 | $9 | $35 |
| Drug injection, under skin or into muscle | 113 | $10 | $96 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 106 | $57 | $211 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 103 | $48 | $313 |
| Administration of chemotherapy into vein, each additional hour | 91 | $22 | $161 |
| Ct scan of chest with contrast | 90 | $51 | $821 |
| Microscopic examination for white blood cells with manual cell count | 85 | $4 | $22 |
| Complete blood count (CBC), automated | 85 | $6 | $34 |
| Red blood count automated, with additional calculations | 81 | $5 | $26 |
| Injection of additional new drug or substance into vein | 71 | $12 | $108 |
| CT scan of abdomen and pelvis with contrast | 67 | $169 | $1,067 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 64 | $90 | $657 |
| Initial hospital admission, high complexity | 55 | $135 | $694 |
| Injection, diphenhydramine hcl, up to 50 mg | 54 | $1 | $7 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 50 | $343 | $1,722 |
| Blood creatinine level | 49 | $5 | $31 |
| Reticulated (young) platelet measurement | 49 | $35 | $143 |
| Unclassified drugs | 49 | $1 | $8 |
| Administration of additional new drug or substance into vein, 1 hour or less | 47 | $48 | $344 |
| Initial hospital admission, moderate complexity | 47 | $101 | $470 |
| PSA test (prostate cancer screening) | 46 | $18 | $94 |
| New patient office visit (45-59 min) | 45 | $115 | $565 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 44 | $1,162 | $4,802 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 44 | $69 | $70 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 36 | $15 | $100 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 | 35 | $20 | $128 |
| Vitamin B-12 level test | 34 | $15 | $76 |
| New patient office visit, complex (60-74 min) | 30 | $162 | $709 |
| Administration of additional new drug or substance into vein using push technique | 24 | $40 | $289 |
| Irrigation of implanted venous access drug delivery device | 23 | $17 | $114 |
| Nuclear medicine study whole body with ct scan | 21 | $1,163 | $4,929 |
| Hospital follow-up visit, high complexity | 21 | $93 | $357 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Griffin is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (low-engagement, top 14%), with 15 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Griffin experienced with iron sucrose injection (venofer)?
Does Dr. Griffin receive payments from pharmaceutical companies?
How do Dr. Griffin's costs compare to other student in an organized health care education/training programs in Fort Worth?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology